AuntMinnie

MARCH 15, 2024

However, increased longevity has brought on a troubling rise in chronic disease, diminishing the quality of life later in life. A 2018 study from the U.S. Centers for Disease Control and Prevention (CDC) found that more than a quarter of U.S. Mark Crockett, MD, chief medical officer at TeleDaaS.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Disease Diagnostic Imaging 105

AuntMinnie

JULY 26, 2024

Evidence showed that Sheriff owned and was pharmacist in charge at Shertech, a pharmacy that provided nuclear and radiopharmaceutical drugs to medical facilities. The resulting diluted product was used in procedures such as renal scans to diagnose various illnesses, such as kidney disease.

Radiopharmaceuticals 98

Radiopharmaceuticals Disease Diagnose Medical 98

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 98

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 98

AuntMinnie

JANUARY 30, 2024

The timing of the new codes dovetails with advances in neuroimaging, such as in the assessment of white-matter diseases. In 2018, Alosco received nearly $800,000 from the National Institutes of Health's National Institute of Neurological Disorders and Stroke for the research. The work builds on previous research.

MRI 105

MRI Radiopharmaceuticals Disease Imaging 105

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. POSLUMA was developed to assist physicians in the detection and localization of prostate cancer.

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97